|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 207/40 | |
| C07D 303/48 | |||
| C07D 493/04 | |||
| C07D 498/14 | |||
| A61K 31/40 | |||
| A61P 9/00 |
| (11) | Number of the document | 1771455 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05760907.5 |
| Date of filing the European patent application | 2005-07-15 | |
| (97) | Date of publication of the European application | 2007-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2005/007739 |
| Date | 2005-07-15 |
| (87) | Number | WO 2006/008091 |
| Date | 2006-01-26 |
| (30) | Number | Date | Country code |
| 200400209 | 2004-07-16 | SI | |
| 200400348 | 2004-12-24 | SI |
| (72) |
GRAHEK, Rok, SI
KOCJAN, Darko, SI
BASTARDA, Andrej, SI
KOCIJAN, Andrej, SI
KRACUN, Matjaz, SI
|
| (73) |
LEK Pharmaceuticals d.d.,
Verovskova 57, 1526 Ljubljana,
SI
|
| (54) | OXIDATIVE DEGRADATION PRODUCTS OF ATORVASTATIN CALCIUM |
| OXIDATIVE DEGRADATION PRODUCTS OF ATORVASTATIN CALCIUM |